UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysis

Journal of hepatology, 2020-06, Vol.72 (6), p.1112-1121

2020

Volltextzugriff (PDF)

Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation

Liver transplantation, 2006-12, Vol.12 (12), p.1791-1798

2006

Volltextzugriff (PDF)

Author's reply: Nucleo(s)tide analogue withdrawal in chronic hepatitis B virus infection. Beyond the HBsAg loss

Digestive and liver disease, 2022-09, Vol.54 (9), p.1283-1284

2022

Volltextzugriff (PDF)

Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study

Journal of hepatology, 2009-04, Vol.50 (4), p.719-728

2009

Volltextzugriff (PDF)

High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study

Hepatology communications, 2022-11, Vol.6 (11), p.3212-3222

2022

Volltextzugriff (PDF)

Potential drug–drug interactions of OMBITASVIR, PARITAPREVIR/ritonavir ± DASABUVIR ± ribavirin in clinical practice

Journal of gastroenterology and hepatology, 2018-05, Vol.33 (5), p.1100-1107

2018

Volltextzugriff (PDF)

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C

World journal of gastroenterology : WJG, 2015-05, Vol.21 (17), p.5421-5426

2015

Volltextzugriff (PDF)

Past, present, and future of long-term treatment for hepatitis B virus

World journal of gastroenterology : WJG, 2023-07, Vol.29 (25), p.3964-3983

2023

Volltextzugriff (PDF)

Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment

Annals of hepatology, 2017-03, Vol.16 (2), p.312-317

2017

Volltextzugriff (PDF)

Severe acute hepatitis in the DRESS syndrome: Report of two cases

Annals of hepatology, 2010-04, Vol.9 (2), p.198-201

2010

Volltextzugriff (PDF)

MR elastography to assess liver fibrosis

Radiology, 2008-05, Vol.247 (2), p.591; author reply 591-592

2008

Volltextzugriff (PDF)

Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study

Gastroenterology (New York, N.Y. 1943), 2007-05, Vol.132 (5), p.1746-1756

2007

Volltextzugriff (PDF)

On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty

Digestive and liver disease, 2022-08, Vol.54 (8), p.1044-1051

2022

Volltextzugriff (PDF)

Elastography is unable to exclude cirrhosis after sustained virological response in HCV‐infected patients with advanced chronic liver disease

Liver international, 2021-11, Vol.41 (11), p.2733-2746

2021

Volltextzugriff (PDF)

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues

PloS one, 2017-11, Vol.12 (11), p.e0188303-e0188303

2017

Volltextzugriff (PDF)

Retransplantation in patients with hepatitis C recurrence after liver transplantation

Journal of hepatology, 2010-11, Vol.53 (5), p.962-970

2010

Volltextzugriff (PDF)

Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years

PloS one, 2016-12, Vol.11 (12), p.e0164883-e0164883

2016

Volltextzugriff (PDF)

Impact of anthropometric features on the applicability and accuracy of FibroScan® (M and XL) in overweight/obese patients

Journal of gastroenterology and hepatology, 2017-10, Vol.32 (10), p.1746-1753

2017

Volltextzugriff (PDF)

Clinical Guideline on Perioperative Management of Patients with Advanced Chronic Liver Disease

Life (Basel, Switzerland), 2023-01, Vol.13 (1), p.132

2023

Volltextzugriff (PDF)

Living donor liver transplantation and hepatitis C: Lessons from the learning curve?

Liver transplantation, 2007-01, Vol.13 (1), p.18-20

2007

Volltextzugriff (PDF)

Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus

Hepatic medicine: evidence and research, 2022-01, Vol.14, p.87-100

2022

Volltextzugriff (PDF)

Follow‐up evaluation of patients with liver test abnormalities detected during SARS‐CoV2 infection

Journal of viral hepatitis, 2022-09, Vol.29 (9), p.823-834

2022

Volltextzugriff (PDF)

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon

PloS one, 2016-11, Vol.11 (11), p.e0166631-e0166631

2016

Volltextzugriff (PDF)

Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients

World journal of hepatology, 2020-11, Vol.12 (11), p.1076-1088

2020

Volltextzugriff (PDF)

1 – 25 von 2.549

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.997)
Mit Volltextzugriff
(2.174)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysis

Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation

Author's reply: Nucleo(s)tide analogue withdrawal in chronic hepatitis B virus infection. Beyond the HBsAg loss

Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study

High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort study

Potential drug–drug interactions of OMBITASVIR, PARITAPREVIR/ritonavir ± DASABUVIR ± ribavirin in clinical practice

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C

Past, present, and future of long-term treatment for hepatitis B virus

Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment

Severe acute hepatitis in the DRESS syndrome: Report of two cases

MR elastography to assess liver fibrosis

Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study

Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid

On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty

Elastography is unable to exclude cirrhosis after sustained virological response in HCV‐infected patients with advanced chronic liver disease

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues

Retransplantation in patients with hepatitis C recurrence after liver transplantation

Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years

Impact of anthropometric features on the applicability and accuracy of FibroScan® (M and XL) in overweight/obese patients

Clinical Guideline on Perioperative Management of Patients with Advanced Chronic Liver Disease

Living donor liver transplantation and hepatitis C: Lessons from the learning curve?

Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus

Follow‐up evaluation of patients with liver test abnormalities detected during SARS‐CoV2 infection

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon

Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients

Suchergebnisse filtern